Dell Just Repriced. Here’s What Changed.
A blowout Q1 report and a $27B guidance hike signal that the AI infrastructure trade is broadening far beyond Nvidia.
The Robotics Revolution Is Moving Off the Factory Floor
Why Humanoid Robotics Is the Most Watched Emerging Theme on Wall Street Right Now
Cybersecurity Stocks Are Quietly Printing New Highs – The Threat Cycle Has Never Been More Investable
Enterprise security spending is accelerating past analyst estimates, and the options market is starting to notice
SpaceX Is Going Public — The SPCX IPO Is the Biggest Market Event of 2026
With a $1.8 trillion floor valuation and a June 12 target listing date, this is the trade event active traders cannot afford to ignore.
Micron’s Memory Is No Longer a Commodity. The Market Is Starting to Figure That Out.
MU just reported $23.86B in quarterly revenue — up nearly 3x year-over-year. Here’s why the real story is still being underpriced.
Eli Lilly (LLY): The GLP-1 Trade Is Bigger Than the Market Thinks
Mounjaro up 125%. Zepbound up 79%. A new oral pill just launched. The growth story keeps widening.
New Fed Chair, Rising Rate Hike Odds, and a Market That’s Still Near All-Time Highs — Something Has to Give
Kevin Warsh just replaced Jerome Powell. Inflation is at 3.8%. The FedWatch Tool is pricing in rate hikes, not cuts. And the S&P 500 is historically expensive. Traders need a framework for what comes next.
The Nuclear Trade Isn’t Hype Anymore. It’s Contracts, Uranium, and 20-Year Deals.
AI data centers are signing decade-long power agreements with nuclear operators. Uranium near $86/lb. SMRs moving from concept to construction. Here’s how to think about the entry.
LLY and the GLP-1 Franchise: What the Options Market Knows That the Headlines Don’t
Eli Lilly’s Q1 blowout reset the ceiling — and the options flow is telling a very specific story
Broadcom (AVGO): The Quiet Engine Behind the AI Infrastructure Supercycle
Custom silicon, record revenue, and a $100B runway — this is not your average chip story.